• Doxepin, Urine
  • Prolyl Hydroxylase Domain-2 (PHD2/EGLN1) Gene Mutation Analysis
  • Hydroxyzine, Serum
  • Breast Cancer Panel
  • TINF2 Gene Mutation Analysis
  • PIK3CA Gene Mutation Analysis (Therascreen PIK3CA)
  • 15q Deletion, Type I and Type II Characterization, Prader-Willi/Angelman Syndromes, FISH
  • Alpha-galactosidase A (GLA) Mutation Analysis
  • Pneumocystis Smear
  • Vancomycin-Resistant Enterococcus, Molecular Detection, PCR
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Circulating Tumor Cells (CTC), Colon Cancer
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Circulating Tumor Cells (CTC), Colon Cancer
Medical Test

Methodology
Access to Circulating Tumor Cells (CTC), Colon Cancer is restricted.
Loading...